Clinical Differences in Patients Infected with<i>Fusobacterium</i>and Antimicrobial Susceptibility of<i>Fusobacterium</i>Isolates Recovered at a Tertiary-Care Hospital in Korea
Myung‐Sook Kim, Shin Young Yun, Yunhee Lee, Hyukmin Lee, Dongeun Yong, Kyungwon Lee
Abstract
Background: isolates. Methods: isolates were selected for antimicrobial susceptibility testing by the agar dilution method, according to the Clinical and Laboratory Standards Institute guidelines (M11-A9). Results: was resistant to clindamycin (48%) and moxifloxacin (24%), and F. mortiferum was resistant to penicillin G (22%) and ceftriaxone (67%). β-Lactamase activity was not detected. Conclusions: infections.
Topics & Concepts
FusobacteriumFusobacterium necrophorumFusobacterium nucleatumMicrobiologyPenicillinClindamycinFusobacteriaAntimicrobialMoxifloxacinMedicineBiologyInternal medicineAntibioticsBacteroidesBacteriaPorphyromonas gingivalisPeriodontitisBacteroidetes16S ribosomal RNAGeneticsOtolaryngology and Infectious DiseasesStreptococcal Infections and TreatmentsInfectious Diseases and Tuberculosis